CVE:BCT

BriaCell Therapeutics (BCT) Stock Price, News & Analysis

BriaCell Therapeutics logo
C$10.60 -0.42 (-3.81%)
As of 12/30/2021

About BriaCell Therapeutics Stock (CVE:BCT)

Key Stats

Today's Range
C$10.60
▼
C$11.07
50-Day Range
C$10.60
▼
C$10.60
52-Week Range
C$3.50
▼
C$15.75
Volume
3,402 shs
Average Volume
12,671 shs
Market Capitalization
C$168.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Receive BCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BCT Stock News Headlines

$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
BriaCell Therapeutics Corp Ordinary Shares - New BCT
See More Headlines

BCT Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at C$10.60 at the beginning of the year. Since then, BCT stock has increased by 0.0% and is now trading at C$10.60.

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
CVE:BCT
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
129.63
Quick Ratio
128.68

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$3.34 per share
Price / Cash Flow
3.17
Book Value
C$3.60 per share
Price / Book
2.94

Miscellaneous

Outstanding Shares
15,913,000
Free Float
N/A
Market Cap
C$168.68 million
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (CVE:BCT) was last updated on 12/30/2021 by MarketBeat.com Staff.
From Our Partners